Leqembi and Kisunla clear amyloid plaques and modestly slow early Alzheimer's. Here's how these drugs work, their risks, and ...

AbbVie’s Juvmo will be available in October as a standalone or add-on therapy for treating Parkinson’s motor symptoms.

Dr. Nathaniel Chin explains why repeat cognitive testing can reveal meaningful changes over time that a single score may miss ...

Deborah Kan is the founder and CEO of Being Patient, a journalism-driven news platform on Alzheimer’s, dementia, and brain ...

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

The symptoms of FTD overlap with many other psychiatric and neurological conditions like depression, bipolar disorder, borderline personality, and Parkinson’s disease. Since the symptoms start young, ...

Dr. Michael Alosco explains what research shows about soccer heading, repetitive head impacts, and CTE risk — and what ...

A new approach to treating Alzheimer’s focuses on targeting dysfunctional cells rather than beta-amyloid or tau tangles.

Sean Terwilliger spent four years trying to get a cognitive test. He discusses his early-onset Alzheimer's diagnosis, 18 months on Leqembi, and how writing helped him find purpose after his diagnosis.

We welcome contributions from dementia and Alzheimer’s caregivers and from people who have or had a loved one with dementia. Think you might have a story to share? Please email [email protected] we ...

October 16, 2026 @ 11:00 am - 11:30 am PDT ...

A dementia diagnosis doesn't mean handing over the keys tomorrow. Here's how to spot the warning signs, get a real driving ...